Helomics Corp-医療機器分野:企業M&A・提携分析

◆英語タイトル:Helomics Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011160
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Helomics Corp(Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor response to various chemotherapeutic and biologic agents. Helomics’ biospecifx is a biomarker that is used to test drug response and patient prognosis. The company also offers contract research, genefx colon, which is a microarray-based gene signature that identifies patients at risk of recurrence. It serves clinical testing, precision medicine and cancer research needs of physicians. The company has operations in US and Canada. Precision is headquartered in Pittsburgh, Pennsylvania, the US.

Helomics Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Helomics Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Helomics Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Helomics Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Helomics Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Helomics Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Helomics Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Precision Therapeutics Raises US$14 Million In Venture Financing 10
Private Equity 11
Healthcare Royalty Invests USD60 Million in Precision Therapeutics 11
Partnerships 12
Med BioGene Enters Into Licensing Agreement With Precision Therapeutics 12
Skyline Medical Forms Joint Venture with Helomics 14
Skyline Medical and Helomics Enter into Partnership 15
Helomics Partners with MDNA Life Sciences 16
Acquisition 17
Skyline Medical to Acquire 25% Stake in Helomics 17
Helomics Corp – Key Competitors 18
Helomics Corp – Key Employees 19
Helomics Corp – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Strategy And Business Planning 21
Jun 01, 2017: Helomics and the Pittsburgh Life Sciences Greenhouse Partner to Establish a Biotechnology Incubator Dedicated to Diagnostics and Precision Medicine 21
Apr 19, 2016: Helomics Announces Second Phase of Realignment Towards a Research and Clinical Products Company in Personalized Healthcare 22
Product News 23
Jun 03, 2016: Helomics to Attend the 2016 BIO International Convention 23
03/15/2016: Helomics Launches GeneFx Colon to Identify Patients with High Risk Stage II Colon Cancer 24
02/08/2016: Helomics Launches CellFx, a Key Research Component of Their Precision Cellular Analytical Platform Further Expanding Their Comprehensive Tumor Profiling Offering to Patients, Physicians and Life Science Industry 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Helomics Corp, Medical Equipment, Key Facts 2
Helomics Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Helomics Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Helomics Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Helomics Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Helomics Corp, Deals By Market, 2011 to YTD 2017 8
Helomics Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Precision Therapeutics Raises US$14 Million In Venture Financing 10
Healthcare Royalty Invests USD60 Million in Precision Therapeutics 11
Med BioGene Enters Into Licensing Agreement With Precision Therapeutics 12
Skyline Medical Forms Joint Venture with Helomics 14
Skyline Medical and Helomics Enter into Partnership 15
Helomics Partners with MDNA Life Sciences 16
Skyline Medical to Acquire 25% Stake in Helomics 17
Helomics Corp, Key Competitors 18
Helomics Corp, Key Employees 19

★海外企業調査レポート[Helomics Corp-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • WorleyParsons Ltd (WOR):企業の財務・戦略的SWOT分析
    WorleyParsons Ltd (WOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • One Lambda Inc-医療機器分野:企業M&A・提携分析
    Summary One Lambda Inc (One Lambda), a subsidiary of Thermo Fisher Scientific Inc is a medical device company that offers laboratory products. The company develops and distributes histocompatibility typing tests and antibody detection products. Its products include HLA tissue typing trays, HLA testi …
  • PromptCare Inc-医療機器分野:企業M&A・提携分析
    Summary PromptCare Inc (PromptCare) is a healthcare center that respiratory products and home infusion services. The center provides respiratory services such as clinical support programs, patient-focused technology and testimonials. It provides home infusion therapies for patients of all ages with …
  • Emerald Health Therapeutics Inc (EMH):製薬・医療:M&Aディール及び事業提携情報
    Summary Emerald Health Therapeutics Inc (Emerald Health), formerly T-Bird Pharma Inc, is a producer of pharmaceutical grade medical cannabis. The company extracts and markets dried cannabis, and cannabis oils and capsules. It offers cannabinoid medicines, which are present in an unparalleled opportu …
  • Viriom Inc-製薬・医療分野:企業M&A・提携分析
    Summary Viriom Inc (Viriom) focuses on the development of antivirals for HIV treatment and prevention. The company’s lead pipeline product candidate Elpida, is a bioavailable prodrug, and VM-1500A, a non-nucleoside HIV reverse transcriptase inhibitor. Its partner portfolio includes Roche, ChemDiv, I …
  • Evonik Industries Ag:企業の戦略・SWOT・財務分析
    Evonik Industries Ag - Strategy, SWOT and Corporate Finance Report Summary Evonik Industries Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • TransForce Inc.:企業のM&A・事業提携・投資動向
    TransForce Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TransForce Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Juvenile Diabetes Research Foundation-医療機器分野:企業M&A・提携分析
    Summary Juvenile Diabetes Research Foundation (JDRF) is a research organization that offers funding services for type one diabetes. The organization conducts clinical trials for curing, preventing and treating for type one diabetes and its complications; and researching new drugs for patients to man …
  • Norwegian Energy Company ASA:企業のM&A・事業提携・投資動向
    Norwegian Energy Company ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Norwegian Energy Company ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • TomTom NV (TOM2):企業の財務・戦略的SWOT分析
    TomTom NV (TOM2) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • RegeneRx Biopharmaceuticals Inc (RGRX):企業の財務・戦略的SWOT分析
    Summary RegeneRx Biopharmaceuticals Inc (RegeneRx) is a clinical-stage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The company offers clinical trials, science and discovery and business development services. Its busine …
  • Aminex PLC (AEX):企業の財務・戦略的SWOT分析
    Summary Aminex PLC (Aminex) is an oil and gas company that explores, develops and produces oil and gas reserves in Africa. The company provides assets such as Valeni field and Viktorovka field in Moldova; West Esh el Mellaha-2 in Egypt; and Kiliwani North development, Nyuni exploration, and Ruvuma e …
  • Ricardo plc:戦略・SWOT・企業財務分析
    Ricardo plc - Strategy, SWOT and Corporate Finance Report Summary Ricardo plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Analytik Jena AG:企業の戦略的SWOT分析
    Analytik Jena AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • H3 Biomedicine Inc-製薬・医療分野:企業M&A・提携分析
    Summary H3 Biomedicine Inc (H3 Biomedicine), a subsidiary of Eisai Co Ltd is a biopharmaceutical company that offers therapies. The company concentrates on discovery and early development of novel, targeted anti-cancer compounds. Its products include small-molecule drugs that are developed by utiliz …
  • Ionis Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報
    Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • BBMG Corporation:企業の戦略・SWOT・財務情報
    BBMG Corporation - Strategy, SWOT and Corporate Finance Report Summary BBMG Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • InterOil Exploration & Production ASA Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    InterOil Exploration & Production ASA Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary InterOil Exploration & Production ASA (InterOil Exploration & Production) is an oil and gas company that provides petroleum exploration services. The company acquires, explores, …
  • Worldpay, Inc.:企業の財務・戦略的SWOT分析
    Worldpay, Inc. - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Noranda Income Fund (NIF.UN):企業の財務・戦略的SWOT分析
    Noranda Income Fund (NIF.UN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆